Anne Li September 16th, 2017 firstname.lastname@example.org
In selected populations of patients with advanced cancer, universal sequencing of germline and tumor DNA for a broad panel of cancer-related genes may detect more potentially clinically significant heritable mutations than a targeted approach based on current clinical guidelines. It is not known if this will result in improved outcomes.
See original article at: http://jamanetwork.com/journals/jama/article-abstract/2652651
Post a comment